<?xml version="1.0" encoding="UTF-8"?>
<ref id="B8">
 <label>8</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Torres-Collado</surname>
    <given-names>AX</given-names>
   </name>
   <name>
    <surname>Knott</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Jazirehi</surname>
    <given-names>AR</given-names>
   </name>
  </person-group>. 
  <article-title>Reversal of resistance in targeted therapy of metastatic melanoma: lessons learned from vemurafenib (BRAFV600E-Specific Inhibitor)</article-title>. 
  <source>Cancers</source> (
  <year>2018</year>) 
  <volume>10</volume>(
  <issue>6</issue>):
  <fpage>157</fpage>. 
  <pub-id pub-id-type="doi">10.3390/cancers10060157</pub-id>
 </mixed-citation>
</ref>
